U-46619-induced potentiation of noradrenergic constriction in the human saphenous vein: Antagonism by thromboxane receptor blockade

Cardiovascular Research

Volumn 52, Issue 3, 2001, Pages 462-467

  Vila, José M ^a   Martínez León, Juan B ^a   Medina, Pascual ^a   Segarra, Gloria ^a   Ballester, Rosa M ^a   Otero, Eduardo ^a   Lluch, Salvador ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Adrenergic (ant)agonists; Ca channel; Endothelial factors; Receptors; Vasoactive agents; Vasoconstriction dilation; Veins

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 7 [3 [(2 HEPTANAMIDOACETAMIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; CALCIUM CHANNEL; NIFEDIPINE; NORADRENALIN; POTASSIUM CHLORIDE; THROMBOXANE RECEPTOR BLOCKING AGENT;

ADRENERGIC TRANSMISSION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG ANTAGONISM; DRUG POTENTIATION; ELECTROSTIMULATION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RECORDING; SAPHENOUS VEIN; TENSION; VENOCONSTRICTION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; AGED; CALCIUM CHANNEL BLOCKERS; DIHYDROPYRIDINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ELECTRIC STIMULATION; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; NIFEDIPINE; NOREPINEPHRINE; POTASSIUM CHLORIDE; RECEPTORS, THROMBOXANE; SAPHENOUS VEIN; STIMULATION, CHEMICAL; THROMBOXANE A2; VASOCONSTRICTOR AGENTS;

EID: 0035216242     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(01)00390-X     Document Type: Article

References (25)

1. 2 on some isolated smooth muscle preparations
2. Pharmacological characterization of thromboxane and prostanoid receptors in human isolated urinary bladder
3. 2 enhances norepinephrine release from adrenergic nerves
4. Thromboxane mimetics enhance adrenergic neurotransmission in the rabbit-isolated portal vein
5. 3H]-noradrenaline release and vascular tone in rat isolated kidney
6. Neuropeptide Y-induced potentiation of noradrenergic vasoconstriction in the human saphenous vein: Involvement of endothelium generated thromboxane
7. Pathologic changes in aortic-coronary arterial saphenous vein grafts
8. Subintimal obliterative proliferation in saphenous vein grafts: A cause of early failure of aorta-to-coronary artery bypass grafts
9. Comparison of late changes in internal mammary artery and saphenous vein grafts in two consecutive series of patients 10 years after operation
10. 2 in porcine coronary artery
11. TXA2-induced pulmonary artery contraction requires extracellular calcium
12. Nimodipine inhibits carbocyclic thromboxane-induced contractions of cerebral arteries
13. 2
14. Endothelium-dependent relaxation of human saphenous veins in response to vasopressin and desmopressin
15. Endothelium-dependent component in the contractile responses of human omental arteries to adrenergic stimulation
16. 3 and DP-receptors
17. 1 vasopressin receptor in human saphenous vein
18. 2α induced contraction
19. 2 receptors: Distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation
20. 2 receptor-mediated contraction in rat aorta
21. In vivo synthesis of thromboxane and prostacyclin in man in health and disease: Data from GC-MS measurements of major urinary metabolites
22. Improved aortocoronary bypass patency by low-dose aspirin (100 mg daily): Effects on platelet aggregation and thromboxane formation
23. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina
24. Aspirin, sulfinpyrazone, or both in unstable angina: Results of a Canadian multicenter trial
25. Endogenous prostacyclin contributes to the efficacy of a thromboxane synthetase inhibitor for preventing coronary artery thrombosis